Xu Jia, Wang Qiuhui, Hu Yishen, Guo Qingfeng, Zhu Hu, Wang Honglin, Hu Hongxin, Wang Shouan, Ye Jianbin
Putian University, School of Basic Medicine Science, Key Laboratory of Translational Tumor Medicine in Fujian Province, Putian City, Fujian Province 351100, China.
Putian University, School of Basic Medicine Science, Key Laboratory of Translational Tumor Medicine in Fujian Province, Putian City, Fujian Province 351100, China; Fujian Province, 351100, China Fujian Medical University, School of Pharmacy, Fuzhou City, Fujian Province 350004, China.
Int J Biol Macromol. 2025 Jun;311(Pt 3):143963. doi: 10.1016/j.ijbiomac.2025.143963. Epub 2025 May 5.
Scutellaria baicalensis extracts (SBACs), a herb that contains a variety of bioactive flavonoids like baicalein and baicalin, which impart antibacterial, antioxidant, and other biological activities, were used to create bacterial cellulose (BC) with a high components-loading capacity in-situ. Higher S-L ratios raised the quantities of the active ingredients (baicalin and baicalein), enhancing antibacterial and antioxidant activities. Considering both components-loading efficiency (322 mg/g of baicalin and 8.79 mg/g of baicalein) and production viability, an S-L ratio of 1:20 was determined as the optimal for preparing BC/SBACs membranes. These membranes exhibited superior mechanical strength and thermal stability compared to pure BC. Furthermore, when compared to membranes made via physical adsorption, the in-situ produced BC/SBACs exhibited a higher capacity for loading components and a more effective release of those components. A three-dimensional network structure was discovered using morphological analysis, which facilitated the integration of active ingredients. In vitro biocompatibility tests showed that BC/SBACs hydrogel was safe, exhibiting no hemolysis and low cytotoxicity. In vivo experiments on a full-thickness skin defect model in mice demonstrated a significantly higher wound-healing rate. The study highlights the potential of BC to improve clinical treatment outcomes by providing an easy way to combine it with traditional Chinese medicine.
黄芩提取物(SBACs)是一种含有多种生物活性黄酮类化合物(如黄芩素和黄芩苷)的草药,这些黄酮类化合物具有抗菌、抗氧化和其他生物活性,被用于原位制备具有高成分负载能力的细菌纤维素(BC)。较高的S-L比提高了活性成分(黄芩苷和黄芩素)的含量,增强了抗菌和抗氧化活性。综合考虑成分负载效率(黄芩苷为322 mg/g,黄芩素为8.79 mg/g)和生产可行性,确定S-L比为1:20是制备BC/SBACs膜的最佳比例。与纯BC相比,这些膜表现出优异的机械强度和热稳定性。此外,与通过物理吸附制备的膜相比,原位制备的BC/SBACs表现出更高的成分负载能力和更有效的成分释放。通过形态分析发现了一种三维网络结构,这有利于活性成分的整合。体外生物相容性测试表明,BC/SBACs水凝胶是安全的,没有溶血现象且细胞毒性低。在小鼠全层皮肤缺损模型上进行的体内实验表明,伤口愈合率显著提高。该研究突出了BC通过提供一种将其与中药结合的简便方法来改善临床治疗效果的潜力。